Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1903-65-7

Post Buying Request

1903-65-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1903-65-7 Usage

Synthesis Reference(s)

The Journal of Organic Chemistry, 51, p. 513, 1986 DOI: 10.1021/jo00354a021

Check Digit Verification of cas no

The CAS Registry Mumber 1903-65-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,9,0 and 3 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1903-65:
(6*1)+(5*9)+(4*0)+(3*3)+(2*6)+(1*5)=77
77 % 10 = 7
So 1903-65-7 is a valid CAS Registry Number.

1903-65-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-ethylpiperidine-4-carboxamide

1.2 Other means of identification

Product number -
Other names N-ethyl-piperidine-4-carboxamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1903-65-7 SDS

1903-65-7Downstream Products

1903-65-7Relevant articles and documents

Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8)

Ghosh, Shomir,Elder, Amy,Guo, Jianping,Mani, Ukti,Patane, Michael,Carson, Kenneth,Ye, Qing,Bennett, Robert,Chi, Shannon,Jenkins, Tracy,Guan, Bing,Kolbeck, Roland,Smith, Sean,Zhang, Cheng,LaRosa, Gregory,Jaffee, Bruce,Yang, Hua,Eddy, Priya,Lu, Chuang,Uttamsingh, Vinita,Horlick, Robert,Harriman, Geraldine,Flynn, Daniel

, p. 2669 - 2672 (2007/10/03)

Activation of CCR8 by its ligand CCL1 may play an important role in diseases such as asthma, multiple sclerosis, and cancer. The study of small molecule CCR8 antagonists will help establish the validation of these hypotheses. We report the design, synthesis, and progress toward optimization of potent small molecule CCR8 antagonists identified from a high-throughput screen. These analogues exhibit good potency in binding and chemotaxis assays, show good selectivity versus the hERG channel, and have good eADME (early absorption, distribution, metabolism, and excretion) profiles.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1903-65-7